Evaluating a Smart Hospital System for COPD Patients
Evaluation of the Effectiveness, Safety, and Cost of a Smart Hospital System for Patients With Chronic Obstructive Pulmonary Disease: Prospective Multicenter Randomized Controlled Trial
NA · Yonsei University · NCT06601777
This study tests if a new home health system can help people with COPD manage their condition better and save on healthcare costs compared to those who start using it later.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 198 (estimated) |
| Ages | 40 Years and up |
| Sex | All |
| Sponsor | Yonsei University (other) |
| Locations | 1 site (Seoul) |
| Trial ID | NCT06601777 on ClinicalTrials.gov |
What this trial studies
This study analyzes the effectiveness, safety, and cost of the Smart Homespital system, which allows patients with Chronic Obstructive Pulmonary Disease (COPD) to access and utilize biosignals generated by medical equipment at home. Participants will be divided into two groups: one receiving immediate application of the system and the other receiving it after a three-month delay. The study aims to determine how this system impacts patient outcomes and healthcare costs associated with COPD management.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with COPD who have specific pulmonary function test results indicating moderate to severe impairment.
Not a fit: Patients who are bedridden, unable to exercise, or currently receiving hospital-centered rehabilitation may not benefit from this study.
Why it matters
Potential benefit: If successful, this system could enhance the management of COPD, leading to improved patient outcomes and reduced healthcare costs.
How similar studies have performed: Other studies have shown promise in using remote monitoring systems for chronic diseases, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients diagnosed with COPD who meet the following pulmonary function test results: 1. Pre FEV1 \< 80% \*\*or\*\* 2. Pre FVC \< 80% \*\*or\*\* 3. DLCO \< 60% Exclusion Criteria: 1. Patients who do not agree to participate in the study. 2. Patients who fail to use the medical device equipment. 3. Patients where tracking during the study period is expected to be impossible. 4. Patients who have difficulty communicating verbally. 5. Patients who are bedridden or unable to exercise at all due to severe cardiorespiratory dysfunction. 6. Patients receiving hospital-centered rehabilitation treatment during the study period.
Where this trial is running
Seoul
- Severance Hospital — Seoul, South Korea (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Chronic Obstructive Pulmonary Disease, COPD